Hepion Pharmaceuticals Inc (NASDAQ:HEPA)
| 9.47 Delayed Data As of Jun 01 |  -0.12 / -1.25%Today’s Change | 5.20 Today|||52-Week Range 23.85 | +57.68% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 16.4K | 21.5K | 21.9K | 18.8K | ||
| Operating Expenses | Gross Income | -16.4K | -21.5K | -21.9K | -18.8K | |
| General Expenses | 13.9M | 20.6M | 21.0M | 14.6M | ||
| Research And Development | 8.4M | 15.0M | 14.3M | 7.6M | ||
| Total Operating Expenses | 14.0M | 20.6M | 21.0M | 14.6M | ||
| Non-Operating Expenses | Operating Income | -14.0M | -20.6M | -21.0M | -14.6M | |
| Extraordinary Credit | 0.00 | 3.8M | 1.1M | 5.3M | ||
| Extraordinary Charge | -387.9K | -214.0K | 0.00 | -374.3K | ||
| Interest Expense On Debt | 0.00 | -- | 0.00 | 339.2K | ||
| Other Expenses | 0.00 | 0.00 | 1.1M | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -14.3M | -17.0M | -18.9M | -10.0M | |
| Income Taxes | 0.00 | 0.00 | -3.9M | -536.0K | ||
| Preferred Dividend | -7.8M | 0.00 | 0.00 | -8.5M | ||
| Net Income | -14.3M | -17.0M | -15.0M | -9.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 38.8K | 48.3K | 138.3K | 183.9K | |
| Shares To Calculate EPS Diluted | 38.8K | 48.3K | 138.3K | 183.9K | ||
| Earnings Per Share | EPS | -$571.20 | -$352.80 | -$56.00 | -$97.30 | |
| EPS Diluted | -$571.20 | -$352.80 | -$106.40 | -$97.35 | ||
